EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for MDGEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2019 0.0025
September 30, 2019 -0.4903
June 30, 2019 -0.7585
March 31, 2019 -0.4983
December 31, 2018 -0.7123
September 30, 2018 -0.4772
June 30, 2018 -0.3588
March 31, 2018 -0.3735
December 31, 2017 -0.2907
September 30, 2017 -0.3344
June 30, 2017 -0.3762
March 31, 2017 -0.3644
December 31, 2016 -0.3891
September 30, 2016 -0.5511
June 30, 2016 0.1072
March 31, 2016 -0.1466
December 31, 2015 -0.2495
September 30, 2015 -0.4855
June 30, 2015 -0.3569
March 31, 2015 -0.5551
December 31, 2014 -0.0237
September 30, 2014 -0.5287
June 30, 2014 -0.1823
March 31, 2014 -0.4944
December 31, 2013 -0.6722
Date Value
September 30, 2013 -0.5281
June 30, 2013 -0.595
March 31, 2013 -0.9027
December 31, 2012 -1.970
September 30, 2012 -0.6649
June 30, 2012 0.5849
March 31, 2012 -0.0001
December 31, 2011 -2.252
September 30, 2011 0.0001
June 30, 2011 -0.7648
March 31, 2011 4.782
September 30, 2010 -1.275
June 30, 2010 -0.2898
March 31, 2010 -0.7349
December 31, 2009 -1.908
September 30, 2009 -2.389
June 30, 2009 -1.964
March 31, 2009 -0.5935
December 31, 2008 -1.701
September 30, 2008 -2.853
June 30, 2008 -2.730
March 31, 2008 -2.958
December 31, 2007 -3.300
September 30, 2007 -2.400
June 30, 2007 -2.048

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
InflaRx NV -0.1052
BioNTech SE -3.799
Immatics NV -0.5316
Arrowhead Pharmaceuticals, Inc. -1.355
Oncolytics Biotech, Inc. -0.0788